As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...
Artificial intelligence (AI) is no longer just a tool for data analysis – it’s rapidly becoming the central nervous system of modern research. Across the life sciences, AI is transforming how ...
Agileo Automation, a leading provider of control and connectivity solutions for global semiconductor manufacturing, unveiled Agil’SECS-II at SEMICON Europa 2025. This new SECS-II library, featuring ...
There are few things as frustrating when you’re trying to get some serious hacking done than intruders repeatedly showing up without permission. [All Parts Combined] has the solution for you, with a ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Four 1.75-metres high robots trundle around a chemistry laboratory at Liverpool university, conveying materials ...
Morphle Labs, Bengaluru-based deep tech healthcare automation company, has raised USD 5 million in a Series A round led by Inflexor Ventures. The company builds robotic and imaging systems for cancer ...
When scientists make the thin metal films used in electronics, optics and quantum technologies, they usually spend months tinkering with the temperature, composition and timing of the process, hoping ...
Intuitive Machines (LUNR) is evolving into a full-service space contractor after acquiring Lanteris Space Systems, expanding capabilities across all major orbital regimes. LUNR shares are down 36% ...
The BioXplorer 5000 is a lab-scale bioreactor platform available in sizes ranging from 1-5L and in high- and low-pressure variants. It can be utilized for a huge variety of applications, ranging from ...
As Hyderabad opens up to wider conversations around fertility, Birla Fertility and IVF is stepping in with a focus on access and trust. With the city expanding and families seeking clearer guidance, ...
AI startup Lila Sciences has raised $115 million in an extension funding round from investors including Nvidia’s venture arm, lifting its valuation to more than $1.3 billion, the company told Reuters.